Bevacizumab vs ranibizumab treatment for age-related macular degeneration - A head-to-head comparison is needed

被引：2
|
作者：
Jampol, Lee M. [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA
来源：
ARCHIVES OF OPHTHALMOLOGY | 2007年 / 125卷 / 04期
关键词：
D O I：
10.1001/archopht.125.4.557
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：557 / 558
页数：2
相关论文
共 50 条
  • [1] Treatment of neovascular age-related macular degeneration with pegaptanib and boosting with bevacizumab or ranibizumab as needed
    Farah, Samer E.
    OPHTHALMIC SURGERY LASERS & IMAGING, 2008, 39 (04) : 294 - 298
  • [2] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [3] COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Stepien, Kimberly E.
    Rosenfeld, Philip J.
    Puliafito, Carmen A.
    Feuer, William
    Shi, Wei
    Al-Attar, Luma
    Dubovy, Sander R.
    Murray, Timothy G.
    Davis, Janet L.
    Lee, Wen-Hsiang
    Schwartz, Stephen G.
    Smiddy, William E.
    Berrocal, Audina M.
    Flynn, Harry W., Jr.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (08): : 1067 - 1073
  • [4] Comparison of Intravitreal Aflibercept with Bevacizumab and Ranibizumab for the Treatment of Wet Age-related Macular Degeneration
    Shaikh, Adeel
    Miller, Daniel
    Petersen, Michael
    Foster, Robert
    Riemann, Christopher
    Sisk, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [5] Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
    Jun Li
    Han Zhang
    Peng Sun
    Feng Gu
    Zhe-Li Liu
    International Journal of Ophthalmology, 2013, (02) : 169 - 173
  • [6] Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
    Li, Jun
    Zhang, Han
    Sun, Peng
    Gu, Feng
    Liu, Zhe-Li
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2013, 6 (02) : 169 - 173
  • [7] Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration
    Abouammoh, Marwan
    Sharma, Sanjay
    CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (03) : 152 - 158
  • [8] Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration
    Gamulescu M.-A.
    Radeck V.
    Lustinger B.
    Bianca Fink B.
    Helbig H.
    International Ophthalmology, 2010, 30 (3) : 261 - 266
  • [9] Pharmacogenetics of the Treatment Response of Age-Related Macular Degeneration with Ranibizumab and Bevacizumab
    Kanoff, Justin
    Miller, Joan
    SEMINARS IN OPHTHALMOLOGY, 2013, 28 (5-6) : 355 - 360
  • [10] Cost Comparison of Intravitreal Aflibercept With Bevacizumab and Ranibizumab for the Treatment of Wet Age-Related Macular Degeneration
    Shaikh, Adeel H.
    Toussaint, Brian W.
    Miller, Daniel M.
    Petersen, Michael R.
    Foster, Robert E.
    Riemann, Christopher D.
    Hutchins, Robert K.
    Sisk, Robert A.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (01): : 62 - 66
12345